ITGAX and neoplasm: Tumor-bearing CD11c:DTA mice also showed a reduction of CD3−CD19−CD127+RORγt+ ILC3s in TdLNs as compared with tumor-bearing WT mice (Supplementary Figures 13P–R in the Supplementary Material).